New cancer clinical trial: Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer

Published on: April 20, 2018 at 12:00PM
Conditions:   Primary Invasive Breast Cancer;   Estrogen Receptor Positive Tumor;   Human Epidermal Growth Factor Receptor 2 Negative Tumor
Intervention:   Other: Observation
Sponsors:   North Eastern Germany Society of Gynaecologic Oncology;   Center for Clinical Trials Philipps University Marburg
Not yet recruiting
https://ift.tt/2Hfyopb